nerby Did a little DD on this company. Although they are a bit ahead of CTIX in the one trial they don't seem to focused on anyone drug. They did a reverse split (10 for 1)back in October of 2016 to up-list to NASQAQ, but that hasn't happened??
On the whole CTIX is ahead of them in drug pipelines and trials, but think CTIX better keep a watchful eywe on them.imo
News 
Market Data 
Discover 
